Moxifioxacin hydrochlodde is one of the two new fluoroquinolonecarboxylic acid antibiotics introduced in 1999 for the treatment of respiratory tract infections such as community-acquired pneumonia, acute exacerbations of bronchitis or acute sinusitis. Moxifloxacin can be synthesized through a 12 step sequence from the classical 4-quinolone-3-carboxylic acid template. Some advantages of Moxifloxacin over Ciprofloxacin, another of Bayer's launched quinolones, have been shown, i.e. an enhanced activity against Gram-positive bacteria (Streptococcus pneumoniae, Clostndium pneumoniae), a favorable pharmacokinetic profile (good tissue penetration and plasma concentrations above MICs) and a lack of phototoxicity (UVA irradiation).
Moxifloxacin can be used to treat social acquired pneumonia caused by Staphylococcus aureus, influenza bacilli, pneumococcus, acute attack of chronic bronchitis, acute sinusitis, etc. It belongs to the fourth generation of quinolone antibiotics and is a new generation of broad spectrum antibiotics. It has strong antimicrobial activity against common respiratory pathogens such as Streptococcus pneumoniae, Haemophilus, Morahan catarrhalis and some Staphylococcus aureus, especially Streptococcus pneumoniae. It is clinically used to treat acute sinus adenitis, acute exacerbation of chronic bronchitis) community acquired pneumonia, as well as non-complications of skin and soft tissue
Moxifloxacin Hydrochloride is a fluoroquinolone antibiotic developed by Bayer Pharmaceuticals (Germany.) It can be used to treat community-acquired pneumonia caused by Staphylococcus aureus, baccilus, pneumococcus, mucositis Moraxella, and Klebsiella pneumoniae, acute chronic bronchitis attacks, and acute sinusitis. For the treatment of adult bacterial lung infections, paranasal sinus, skin, and abdominal cavity. Also used to treat community-acquired pneumonia, chronic bronchitis, urogenital infection, and acute sinusitis.
ພວກເຮົາມີໂຮງງານທີ່ມີຄຸນນະພາບສູງຫຼາຍທີ່ມີການຮ່ວມມືຢ່າງເລິກເຊິ່ງ, ເຊິ່ງສາມາດໃຫ້ທ່ານຜະລິດຕະພັນທີ່ມີຄຸນນະພາບສູງແລະລາຄາທີ່ແຂ່ງຂັນ. ແລະພວກເຮົາຍັງສາມາດໃຫ້ສ່ວນຫຼຸດສໍາລັບການຊື້ຈໍານວນຫລາຍ.ແລະພວກເຮົາຮ່ວມມືກັບບໍລິສັດຂົນສົ່ງສິນຄ້າມືອາຊີບຈໍານວນຫຼາຍ, ສາມາດຈັດສົ່ງຜະລິດຕະພັນໄດ້ຢ່າງປອດໄພແລະກ້ຽງກັບມືຂອງທ່ານ. ເວລາສົ່ງແມ່ນປະມານ 3-20 ມື້ຫຼັງຈາກຢືນຢັນການຈ່າຍເງິນ.
Items |
Standard |
ຜົນໄດ້ຮັບ |
ຮູບລັກສະນະ | Yellow crystalline powder | Conforms |
Crystallinity | Conforms | Conforms |
Identification | Conforms | Conforms |
Water | 4.3~8.0% | 6.7% |
PH | 3.4-4.5 | 3.9 |
Related substances | Epiminocycline ≤1.2% Any other impurity ≤1.2% Total impurities other than epiminocycline ≤2.0% |
0.47% 0.47% 1.5% |
Residue on ignition | ≤0.15% | 0.09% |
Heavy metals | ≤50ppm | <50ppm |
Residual solvent | Carbinol ≤0.3% | <0.08% |
ວິເຄາະ | 890ug/mg~950ug/mg | 900ug/mg |
ວິເຄາະ | 96.0~102.0% (Drying basis) | 98.4% |
ສະຫຼຸບ | Complies with USP38 standard. |
Minocycline Hydrochloride is a semisynthetic tetracycline class,broad-spectrum antibiotics in the tetracycline class of antibiotics,the product of the strongest activity.To gram-positive bacteria including tetracycline resistance of staphylococcus aureus,streptococcus and gram-negative bacteria such as gonorrhea netheril bacteria have a strong role; For chlamydia trachomatis and dissolving urea mycoplasma also has better inhibition.
1. ເຈົ້າເປັນໂຮງງານຫຼືບໍລິສັດການຄ້າບໍ?
ພວກເຮົາແມ່ນ compnay ອຸດສາຫະກໍາປະສົມປະສານແລະການຄ້າ, ການສະຫນອງການບໍລິການທີ່ຢຸດດຽວ.OEM ສາມາດໄດ້ຮັບການຍອມຮັບ.
2. ເຈົ້າໃຫ້ຕົວຢ່າງບໍ? ມັນບໍ່ເສຍຄ່າຫຼືພິເສດບໍ?
ຕົວຢ່າງຟຣີ.ຄ່າທໍານຽມການຂົນສົ່ງຂອງຕົວຢ່າງຈໍາເປັນຕ້ອງຈ່າຍໂດຍຂ້າງຂອງທ່ານ.
3. ທ່ານມີໃບຢັ້ງຢືນທີ່ກ່ຽວຂ້ອງກັບການຄວບຄຸມຄຸນນະພາບບໍ?
ການຢັ້ງຢືນ ISO 9001: 2008 ເພື່ອຮັບປະກັນຄຸນນະພາບ.
4. ຂ້ອຍຄວນຈັດຫາຫຍັງເພື່ອໃຫ້ໄດ້ໃບສະເໜີລາຄາ?
Pls ແຈ້ງພວກເຮົາກ່ຽວກັບປະເພດຜະລິດຕະພັນທີ່ທ່ານຕ້ອງການ, ຈໍານວນການສັ່ງຊື້, ທີ່ຢູ່ແລະຄວາມຕ້ອງການສະເພາະ.
5. ເຈົ້າມັກວິທີຈ່າຍເງິນແບບໃດ? ປະເພດໃດແດ່ທີ່ຍອມຮັບ?
ເງື່ອນໄຂການຈັດສົ່ງທີ່ຍອມຮັບ: FOB, CFR, CIF, EXW;
ສະກຸນເງິນທີ່ຍອມຮັບ: USD;
ປະເພດການຈ່າຍເງິນທີ່ຍອມຮັບ: T / T, Western Union; Paypal, ປະກັນການຄ້າ.
ພາສາເວົ້າ: ພາສາອັງກິດ.
ປະເພດຜະລິດຕະພັນ